\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ available\ \(6\)\
\-\ fluroscopic\\ ercp\\ images\\ after\\ contrast\\ infusion\\ into\\ the\\ common\\ bile\\ duct\\ demonstrate\\ multifocal\\ areas\\ of\\ stricture\\ and\\ dilatation\\ in\\ the\\ intrahepatic\\ and\\ extrahepatic\\ ducts\\.\ \(0\)\
\-\ primary\\ sclerosing\\ cholangitis\ \(2\)\
\-\ primary\\ sclerosing\\ cholangitis\ \(2\)\
\-\ secondary\\ sclerosing\\ cholangitis\\ due\\ to\\ \ \(0\)\
\-\ \\ \\-\\ inflammatory\\ bowel\\ disease\\ \ \(0\)\
\-\ \\ \\-\\ bacterial\\/aids\\ cholangitis\ \(0\)\
\-\ \\ \\-\\ chronic\\ obstruction\\ from\\ stones\\ \ \(0\)\
\-\ \\ \\-\\ chemotherapy\\ related\ \(0\)\
\-\ \\ \\-\\ ischemia\ \(0\)\
\-\ diffuse\\ cholangiocarcinoma\ \(0\)\
\-\ with\\ pain\\,\\ jaundice\\,\\ pruritus\\ and\\ elevated\\ liver\\ function\\ tests\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cholangitis\\:\\ 0\\.33161556433050304\ \(0\)\
\-\ sclerosing\\:\\ 0\\.2229846312473354\ \(0\)\
\-\ \\-\\:\\ 0\\.13468591608149733\ \(0\)\
\-\ bacterial\\/aids\\:\\ 0\\.12963997682303674\ \(0\)\
\-\ fluroscopic\\:\\ 0\\.10102365110163507\ \(0\)\
\-\ pruritus\\:\\ 0\\.10102365110163507\ \(0\)\
\-\ ercp\\:\\ 0\\.08418347015600268\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.08290389108262576\ \(0\)\
\-\ infusion\\:\\ 0\\.0823035676337985\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.07914016499237282\ \(0\)\
\-\ jaundice\\:\\ 0\\.07502862290091457\ \(0\)\
\-\ primary\\:\\ 0\\.07445247832046166\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.07399012926541525\ \(0\)\
\-\ ducts\\:\\ 0\\.07211022674321106\ \(0\)\
\-\ multifocal\\:\\ 0\\.06758839292338811\ \(0\)\
\-\ stricture\\:\\ 0\\.06737370469660645\ \(0\)\
\-\ bile\\:\\ 0\\.06716210561642852\ \(0\)\
\-\ tests\\:\\ 0\\.06576048532518844\ \(0\)\
\-\ stones\\:\\ 0\\.06465702670838089\ \(0\)\
\-\ ischemia\\:\\ 0\\.05840193143393981\ \(0\)\
\-\ duct\\:\\ 0\\.05761292094140569\ \(0\)\
\-\ dilatation\\:\\ 0\\.05385627690395175\ \(0\)\
\-\ function\\:\\ 0\\.05327296430994541\ \(0\)\
\-\ related\\:\\ 0\\.05187134401870534\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04504332036971861\ \(0\)\
\-\ obstruction\\:\\ 0\\.04431470659690346\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0435781756498827\ \(0\)\
\-\ liver\\:\\ 0\\.043326786924010645\ \(0\)\
\-\ elevated\\:\\ 0\\.04263700531410387\ \(0\)\
\-\ areas\\:\\ 0\\.04228451722420686\ \(0\)\
\-\ available\\:\\ 0\\.04224586836529114\ \(0\)\
\-\ bowel\\:\\ 0\\.03941108136595234\ \(0\)\
\-\ diffuse\\:\\ 0\\.03804422677022522\ \(0\)\
\-\ chronic\\:\\ 0\\.03539690636627941\ \(0\)\
\-\ secondary\\:\\ 0\\.03513279362512952\ \(0\)\
\-\ due\\:\\ 0\\.03353348754342411\ \(0\)\
\-\ common\\:\\ 0\\.032886282528770544\ \(0\)\
\-\ none\\:\\ 0\\.031172345689823626\ \(0\)\
\-\ into\\:\\ 0\\.02990185835234863\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02891841384313295\ \(0\)\
\-\ contrast\\:\\ 0\\.028129054217763315\ \(0\)\
\-\ after\\:\\ 0\\.026000017685429446\ \(0\)\
\-\ images\\:\\ 0\\.024106821940431677\ \(0\)\
\-\ disease\\:\\ 0\\.020540257959054474\ \(0\)\
\-\ from\\:\\ 0\\.018624054605209005\ \(0\)\
\-\ pain\\:\\ 0\\.01534717893427551\ \(0\)\
\-\ \\,\\:\\ 0\\.007962060750508452\ \(0\)\
\-\ and\\:\\ 0\\.007941573782303755\ \(0\)\
\-\ to\\:\\ 0\\.00628041335945568\ \(0\)\
\-\ in\\:\\ 0\\.006197018090297867\ \(0\)\
\-\ the\\:\\ 0\\.004066155432459582\ \(0\)\
\-\ with\\:\\ 0\\.0017206496483807314\ \(0\)\
\-\ of\\:\\ 0\\.0017132911882057121\ \(0\)\
\-\ \\.\\:\\ 0\\.0005220520014315628\ \(0\)\
